PAG
FTXH icon

Private Advisor Group’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Private Advisor Group’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,076
Closed -$277K – 2655
2026
Q1 		$277K Sell
8,076
-3,300
-29% -$113K ﹤0.01% 2235
2025
Q4 		$375K Buy
+11,376
New +$354K ﹤0.01% 2008
2020
Q3 		– Sell
-640
Closed -$15K – 2273
2020
Q2 		$15K Buy
+640
New +$14.2K ﹤0.01% 2720

Other funds holding FTXH

Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Private Advisor Group's FTXH Position: Q2 2026 in Review

Private Advisor Group sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2026, closing a stake of 8,076 shares — an estimated $277K sold.

Private Advisor Group first reported a position in FTXH in Q2 2020 and held it in 3 quarters. The position peaked at $375K in Q4 2025. 8 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

  • Private Advisor Group reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • Private Advisor Group sold 8,076 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $277K.
  • Private Advisor Group first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2020 and held it in 3 quarters.
  • Private Advisor Group's First Trust Nasdaq Pharmaceuticals ETF position peaked at $375K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.